Cargando…
Targeting SARS-CoV-2-Platelet Interactions in COVID-19 and Vaccine-Related Thrombosis
It is clear that COVID-19 is more than a pneumonia and is associated with a coagulopathy and multi-organ failure. While the use of anti-coagulants does reduce the incidence of pulmonary emboli, it does not help with survival. This suggests that the coagulopathy is more likely to be platelet-driven r...
Autor principal: | Cox, Dermot |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287727/ https://www.ncbi.nlm.nih.gov/pubmed/34290613 http://dx.doi.org/10.3389/fphar.2021.708665 |
Ejemplares similares
-
Phytochemicals as Potential Therapeutics for SARS-CoV-2–Induced Cardiovascular Complications: Thrombosis and Platelet Perspective
por: Beura, Samir K., et al.
Publicado: (2021) -
A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic
por: Funk, Colin D., et al.
Publicado: (2020) -
Anti-SARS-CoV Natural Products With the Potential to Inhibit SARS-CoV-2 (COVID-19)
por: Verma, Surjeet, et al.
Publicado: (2020) -
SARS-CoV-2: Pathogenesis, Molecular Targets and Experimental Models
por: Kanimozhi, G., et al.
Publicado: (2021) -
SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19
por: Zhang, Si, et al.
Publicado: (2020)